FDA recall record

Nipro Renal Soultions USA MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 recall — FDA Z-3134-2026

Hemodialysis concentrates contain high endotoxin levels

Class IIclassification
Z-3134-2026official record ID
Sep 16, 2026report date

Recall record at a glance

Official recordZ-3134-2026
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmNipro Renal Soultions USA, Corporation
Report dateSep 16, 2026
Recall initiation dateAug 5, 2026
Quantity2,327 cases
LocationLewisberry, PA, United States

Official product description

MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))

Why the product was recalled

Hemodialysis concentrates contain high endotoxin levels

Distribution information

Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.